Technology Spotlight As part of its "Health AI Developer Foundations" program, Google Research has officially released a dual-model open AI... Read more
Tag: #Global Trends
Novartis and AstraZeneca drive new deals at JPM 2026
Conference Updates The second day of the industry's premier healthcare event in San Francisco continued to showcase strong investment in... Read more
Anthropic unveils “Claude for Healthcare” to rival ChatGPT at JPM 2026
HealthTech News At the 2026 J.P. Morgan Healthcare Conference, Anthropic officially launched Claude for Healthcare, a comprehensive suite of AI... Read more
UK introduces clinical trial reforms to boost medical research appeal
Regulatory Update The UK government has announced major reforms to its clinical trial regulatory framework, set to take effect this... Read more
MRM Health receives FDA green light for microbiome-based ulcerative colitis trial
Research Update The U.S. Food and Drug Administration (FDA) has formally cleared the Investigational New Drug (IND) application for MH002,... Read more
Camzyos reports positive Phase III results for adolescent heart disease
Clinical News Bristol Myers Squibb (BMS) has announced successful top-line results from its Phase III SCOUT-HCM trial. This marks the... Read more
Axol Bioscience secures $2.8M for U.S. expansion and R&D
Investment Update U.K.-based Axol Bioscience, a specialist in induced pluripotent stem cell (iPSC) technologies, has secured $2.8 million (£2.1 million)... Read more
Gilead HIV pipeline dosing optionality offers strategic competitive advantage
Strategic Spotlight At the 44th Annual J.P. Morgan Healthcare Conference, CEO Daniel O’Day outlined Gilead’s roadmap to sustain its dominance... Read more
Sarepta seeks to restore gene therapy confidence after a turbulent year
Medical Spotlight At the 2026 J.P. Morgan Healthcare Conference, Sarepta Therapeutics CEO Douglas Ingram offered an optimistic outlook for the... Read more









